Literature DB >> 35156173

Activation of SIRT-1 Signalling in the Prevention of Bipolar Disorder and Related Neurocomplications: Target Activators and Influences on Neurological Dysfunctions.

Bidisha Rajkhowa1, Sidharth Mehan2, Pranshul Sethi1, Aradhana Prajapati1.   

Abstract

SIRT-1 (silent mating-type information regulation 2 homolog-1) is a protein found in neuronal nuclei, microglia, and astrocyte cells of the brain. It is sometimes referred to as NAD + -dependent deacetylase (nicotinamide adenine dinucleotide). The activation of sirtuins (SIRT-1-7) has been shown to protect against a wide range of disorders, including neurodegenerative and neuropsychiatric disorders. SIRT-1 has gained considerable interest from these families because of its early link to long-life expansion and calorie restriction involvement. SIRT-1 is necessary for gene silencing, cell cycle regulation, fat and glucose metabolism, oxidative stress, ageing, and memory formation. In this review, we investigate the role of SIRT-1 downregulation in the progression of bipolar disorder (BD) and neurological abnormalities, as well as related neurological alterations such as genetic dysfunction, neurotransmitter imbalance, oxidative stress-induced apoptosis, and mitochondrial dysfunction. BD is a psychiatric disease distinguished by extreme mood fluctuations that range from depressive lows to manic highs. BD is a complicated disorder with numerous clinical signs and neurocomplications that produce significant behavioural problems. SIRT-1 deficiency in the brain has been demonstrated to affect the activity of its transcription factors and molecular changes, including genetic defects. SIRT-1 is now being studied as a potential therapeutic target for a range of brain disorders. A recent study also found that activating SIRT-1 signalling performs a protective effect in avoiding depression and mania-like behaviours. Furthermore, this review investigates the potential mechanisms by which SIRT-1 regulates neuronal transmission and neurogenesis. As a result of our review, we revealed that SIRT-1 activators have neuroprotective potential in BD and related neurological dysfunctions.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bipolar disorder; Immune dysfunction; Neuroinflammation; SIRT-1; Serotonin

Mesh:

Substances:

Year:  2022        PMID: 35156173     DOI: 10.1007/s12640-022-00480-z

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  57 in total

1.  NiO nanoparticles induce apoptosis through repressing SIRT1 in human bronchial epithelial cells.

Authors:  Wei-Xia Duan; Min-Di He; Lin Mao; Feng-Hua Qian; Yu-Ming Li; Hui-Feng Pi; Chuan Liu; Chun-Hai Chen; Yong-Hui Lu; Zheng-Wang Cao; Lei Zhang; Zheng-Ping Yu; Zhou Zhou
Journal:  Toxicol Appl Pharmacol       Date:  2015-04-01       Impact factor: 4.219

Review 2.  SIRT1 and SIRT6 Signaling Pathways in Cardiovascular Disease Protection.

Authors:  Nunzia D'Onofrio; Luigi Servillo; Maria Luisa Balestrieri
Journal:  Antioxid Redox Signal       Date:  2017-06-29       Impact factor: 8.401

3.  Altered sirtuin deacetylase gene expression in patients with a mood disorder.

Authors:  Naoko Abe; Shusaku Uchida; Koji Otsuki; Teruyuki Hobara; Hirotaka Yamagata; Fumihiro Higuchi; Tomohiko Shibata; Yoshifumi Watanabe
Journal:  J Psychiatr Res       Date:  2011-02-23       Impact factor: 4.791

4.  Hippocampal Sirtuin 1 Signaling Mediates Depression-like Behavior.

Authors:  Naoko Abe-Higuchi; Shusaku Uchida; Hirotaka Yamagata; Fumihiro Higuchi; Teruyuki Hobara; Kumiko Hara; Ayumi Kobayashi; Yoshifumi Watanabe
Journal:  Biol Psychiatry       Date:  2016-01-30       Impact factor: 13.382

5.  Identification of a SIRT1 mutation in a family with type 1 diabetes.

Authors:  Anna Biason-Lauber; Marianne Böni-Schnetzler; Basil P Hubbard; Karim Bouzakri; Andrea Brunner; Claudia Cavelti-Weder; Cornelia Keller; Monika Meyer-Böni; Daniel T Meier; Caroline Brorsson; Katharina Timper; Gil Leibowitz; Andrea Patrignani; Remy Bruggmann; Gino Boily; Henryk Zulewski; Andreas Geier; Jennifer M Cermak; Peter Elliott; James L Ellis; Christoph Westphal; Urs Knobel; Jyrki J Eloranta; Julie Kerr-Conte; François Pattou; Daniel Konrad; Christian M Matter; Adriano Fontana; Gerhard Rogler; Ralph Schlapbach; Camille Regairaz; José M Carballido; Benjamin Glaser; Michael W McBurney; Flemming Pociot; David A Sinclair; Marc Y Donath
Journal:  Cell Metab       Date:  2013-03-05       Impact factor: 27.287

6.  Pharmacological modulation of circadian rhythms by synthetic activators of the deacetylase SIRT1.

Authors:  Marina M Bellet; Yasukazu Nakahata; Mohamed Boudjelal; Emma Watts; Danuta E Mossakowska; Kenneth A Edwards; Marlene Cervantes; Giuseppe Astarita; Christine Loh; James L Ellis; George P Vlasuk; Paolo Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

7.  SIRT1 Overexpression in Mouse Hippocampus Induces Cognitive Enhancement Through Proteostatic and Neurotrophic Mechanisms.

Authors:  Rubén Corpas; Susana Revilla; Suzanna Ursulet; Marco Castro-Freire; Perla Kaliman; Valérie Petegnief; Lydia Giménez-Llort; Chamsy Sarkis; Mercè Pallàs; Coral Sanfeliu
Journal:  Mol Neurobiol       Date:  2016-09-10       Impact factor: 5.590

8.  Melatonin-mediated mitophagy protects against early brain injury after subarachnoid hemorrhage through inhibition of NLRP3 inflammasome activation.

Authors:  Shenglong Cao; Sudeep Shrestha; Jianru Li; Xiaobo Yu; Jingyin Chen; Feng Yan; Guangyu Ying; Chi Gu; Lin Wang; Gao Chen
Journal:  Sci Rep       Date:  2017-05-25       Impact factor: 4.379

9.  Activation of Nrf2 Reduces UVA-Mediated MMP-1 Upregulation via MAPK/AP-1 Signaling Cascades: The Photoprotective Effects of Sulforaphane and Hispidulin.

Authors:  Anyamanee Chaiprasongsuk; Jinaphat Lohakul; Kitipong Soontrapa; Somponnat Sampattavanich; Pravit Akarasereenont; Uraiwan Panich
Journal:  J Pharmacol Exp Ther       Date:  2016-12-23       Impact factor: 4.030

10.  5-Hydroxytryptamine Modulates Maturation and Mitochondria Function of Human Oligodendrocyte Progenitor M03-13 Cells.

Authors:  Simona Damiano; Giuliana La Rosa; Concetta Sozio; Gina Cavaliere; Giovanna Trinchese; Maddalena Raia; Roberto Paternò; Maria Pina Mollica; Vittorio Enrico Avvedimento; Mariarosaria Santillo
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.